1-8 of 8
Andrew J. Gifford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B003: Expanding therapeutic horizons: Unleashing the untapped potential of MEK inhibitor treatment in pediatric cancers

Gabor Tax, Jie Mao, Roxanne Cadiz, Tamar Barhen, Jinhan Xie, Jessica Harris, Mirae Bae, Lauren M. Brown, Karina Pazaky, Andrew J. Gifford, Chelsea Mayoh, Marion K. Mateos, Heike Peterziel, Ina Oehme, David S. Ziegler, Maria Tsoli, Ben Rayner, Paul G. Ekert, M. Emmy M. Dolman
Journal: Cancer Research
Cancer Res (2024) 84 (17_Supplement): B003.
https://doi.org/10.1158/1538-7445.PEDIATRIC24-B003
Published: 05 September 2024
View articletitled, Abstract B003: Expanding therapeutic horizons: Unleashing the untapped potential of MEK inhibitor treatment in pediatric cancers
Journal Articles

High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer

Chelsea Mayoh, Jie Mao, Jinhan Xie, Gabor Tax, Shu-Oi Chow, Roxanne Cadiz, Karina Pazaky, Paulette Barahona, Pamela Ajuyah, Peter Trebilcock, Angela Malquori, Kate Gunther, Anica Avila, Doo Young Yun, Stephanie Alfred, Anjana Gopalakrishnan, Alvin Kamili, Marie Wong, Mark J. Cowley, Sophie Jessop, Loretta M.S. Lau, Toby N. Trahair, David S. Ziegler, Jamie I. Fletcher, Andrew J. Gifford, Maria Tsoli, Glenn M. Marshall, Michelle Haber, Vanessa Tyrrell, Timothy W. Failes, Greg M. Arndt, Richard B. Lock, Paul G. Ekert, M. Emmy M. Dolman
Journal: Cancer Research
Cancer Res (2023) 83 (16): 2716–2732.
https://doi.org/10.1158/0008-5472.CAN-22-3702
Published: 15 August 2023
View articletitled, High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Open the PDF for High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer in another window
Includes: Supplementary data
Journal Articles

Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression

Jixuan Gao, MoonSun Jung, Chelsea Mayoh, Pooja Venkat, Katherine M. Hannan, Jamie I. Fletcher, Alvin Kamili, Andrew J. Gifford, Eric P. Kusnadi, Richard B. Pearson, Ross D. Hannan, Michelle Haber, Murray D. Norris, Klaartje Somers, Michelle J. Henderson
Journal: Cancer Research
Cancer Res (2020) 80 (17): 3706–3718.
https://doi.org/10.1158/0008-5472.CAN-19-3914
Published: 02 September 2020
View articletitled, Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression
Open the PDF for Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression in another window
Includes: Supplementary data
Journal Articles

Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface

Jessica Koach, Jessica K. Holien, Hassina Massudi, Daniel R. Carter, Olivia C. Ciampa, Mika Herath, Taylor Lim, Janith A. Seneviratne, Giorgio Milazzo, Jayne E. Murray, Joshua A. McCarroll, Bing Liu, Chelsea Mayoh, Bryce Keenan, Brendan W. Stevenson, Michael A. Gorman, Jessica L. Bell, Larissa Doughty, Stefan Hüttelmaier, Andre Oberthuer, Matthias Fischer, Andrew J. Gifford, Tao Liu, Xiaoling Zhang, Shizhen Zhu, W. Clay Gustafson, Michelle Haber, Murray D. Norris, Jamie I. Fletcher, Giovanni Perini, Michael W. Parker, Belamy B. Cheung, Glenn M. Marshall
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (21): 5652–5667.
https://doi.org/10.1158/0008-5472.CAN-19-1112
Published: 01 November 2019
View articletitled, Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Open the PDF for Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface in another window
Includes: Supplementary data
Journal Articles

Abstract 4824: Targeting CD30 as a novel treatment strategy in RANBP2-ALK-rearranged inflammatory myofibroblastic tumor

Ashleigh M. Fordham, James Blackburn, Erin E. Heyer, Jinhan Xie, Emily V. Mould, Andrew J. Gifford, Lisa T. Morgan, Carol Wadham, Mitali Fadia, Jamie I. Fletcher, Karen L. MacKenzie, Toby N. Trahair
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4824.
https://doi.org/10.1158/1538-7445.AM2019-4824
Published: 01 July 2019
View articletitled, Abstract 4824: Targeting CD30 as a novel treatment strategy in RANBP2-ALK-rearranged inflammatory myofibroblastic tumor
Journal Articles

Abstract 2884: Establishment of patient-derived xenograft models for high-risk neuroblastoma

Alvin Kamili, Andrew J. Gifford, Nancy Li, Chelsea Mayoh, Georgina L. Eden, Jinhan Xie, Robyn E. Lukeis, Murray D. Norris, Michelle Haber, Geoffrey McCowage, Toby N. Trahair, Jamie I. Fletcher
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2884.
https://doi.org/10.1158/1538-7445.AM2019-2884
Published: 01 July 2019
View articletitled, Abstract 2884: Establishment of patient-derived xenograft models for high-risk neuroblastoma
Journal Articles

Abstract 4741: Re-evaluating the role of P-glycoprotein in the resistance of high-risk neuroblastoma to standard-of-care chemotherapies

Caroline Atkinson, Carole M. Tactacan, Alvin Kamili, Federica Saletta, Christine Gana, Georgina L. Eden, Chelsea Mayoh, Richard B. Lock, Murray D. Norris, Michelle Haber, Andrew J. Gifford, Toby N. Trahair, Jamie I. Fletcher
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4741.
https://doi.org/10.1158/1538-7445.AM2019-4741
Published: 01 July 2019
View articletitled, Abstract 4741: Re-evaluating the role of P-glycoprotein in the resistance of high-risk neuroblastoma to standard-of-care chemotherapies
Journal Articles

A polymorphism in the reduced folate carrier gene but not the methylenetetrahydrofolate reductase gene predicts clinical outcome in children with ALL.

Lesley J. Ashton, Andrew J. Gifford, Edward Kwan, Glenn Marshall, Michelle Haber, Murray Norris
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 117.
Published: 01 May 2005
View articletitled, A polymorphism in the reduced folate carrier gene but not the methylenetetrahydrofolate reductase gene predicts clinical outcome in children with ALL.